Bottom line
How much do SWHFX and QAAGZX overlap?
73% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 55.3% of SWHFX's assets and 53.9% of QAAGZX's. They are largely the same portfolio — owning both adds little diversification.
QAAGZX holds far more positions (277 vs 80), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings SWHFX and QAAGZX have in common
| Holding | % of SWHFX | % of QAAGZX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.92% | 14.06% | 13.92% |
| Johnson & Johnson | 6.94% | 6.64% | 6.64% |
| AbbVie Inc | 5.81% | 5.12% | 5.12% |
| Merck & Co Inc | 4.98% | 4.00% | 4.00% |
| UnitedHealth Group Inc | 4.74% | 5.88% | 4.74% |
| Gilead Sciences Inc | 3.24% | 2.79% | 2.79% |
| Amgen Inc | 2.58% | 1.80% | 1.80% |
| Bristol-Myers Squibb Co | 2.44% | 2.12% | 2.12% |
| Thermo Fisher Scientific Inc | 2.16% | 2.53% | 2.16% |
| Stryker Corp | 2.11% | 1.78% | 1.78% |
| Vertex Pharmaceuticals Inc | 1.89% | 2.26% | 1.89% |
| Abbott Laboratories | 1.60% | 1.91% | 1.60% |
| Danaher Corp | 1.47% | 1.44% | 1.44% |
| Elevance Health Inc | 1.45% | 1.54% | 1.45% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in SWHFX
- Novartis AG — 2.92%
- Medtronic PLC — 2.29%
- Roche Holding AG — 2.29%
- Gsk Plc — 1.73%
- Boston Scientific Corp — 1.60%
- Cigna Group/The — 1.51%
- Incyte Corp — 1.37%
- Ipsen SA — 1.34%
- Sanofi SA — 1.31%
- Becton Dickinson & Co — 1.24%
- Astellas Pharma Inc — 1.19%
Only in QAAGZX
- Intuitive Surgical Inc — 1.89%
- Natera Inc — 1.44%
- Guardant Health Inc — 1.22%
- Cardinal Health Inc — 1.04%
- Royalty Pharma Plc- Cl A — 0.97%
- Tenet Healthcare Corp — 0.94%
- Cvs Health Corp — 0.93%
- Kymera Therapeutics Inc — 0.89%
- T. Rowe Price Government Reserve Fund — 0.87%
- Protagonist Therapeutics Inc — 0.85%
- Moderna Therapeutics Inc — 0.83%
Asset mix
| Asset type | SWHFX | QAAGZX |
|---|---|---|
| Stocks | 99.0% | 96.9% |
| Preferred stock | — | 2.2% |
| Cash & short-term funds | — | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | SWHFX | QAAGZX |
|---|---|---|
| US | 78.6% | 92.3% |
| CH | 5.2% | 0.5% |
| IE | 4.5% | 0.8% |
| GB | 3.4% | 1.8% |
| FR | 2.6% | 0.3% |
| JP | 2.3% | 0.5% |
| NL | 0.7% | 1.0% |
| BM | — | 0.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do SWHFX and QAAGZX overlap?
What stocks do SWHFX and QAAGZX have in common?
Should I own both SWHFX and QAAGZX?
Which holds more stocks, SWHFX or QAAGZX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.